Prostate Cancer Clinical Trial

Clinical Trial Finder Prostate Cancer Trials

Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

See Locations Near You

Summary

The purpose of this study is to evaluate safety and tolerability of ODM-201 in patients with castrate resistant prostate cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Written informed consent
Successful completion of study protocol 3104001
Response or stable disease in study 3104001 at week 12

Exclusion Criteria:

New serious concurrent medical condition
Not able to swallow the study drug

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

76

Study ID:

NCT01429064

Recruitment Status:

Completed

Sponsor:

Orion Corporation, Orion Pharma

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

The Urology Center of Colorado
Wheat Ridge Colorado, 80211, United States
Eastern CT Hematology and Oncology Associates
Norwich Connecticut, 06360, United States
Cleveland Clinic
Cleveland Ohio, 44195, United States
Carolina Urologic Research Center
Myrtle Beach South Carolina, 29572, United States
Klinika onkologie a radioterapie LFUK a FN
Hradec Králové , , Czech Republic
East-Tallinn Central Hospital
Tallinn , , Estonia
Helsinki University Central Hospital
Helsinki , , Finland
Kuopio University Hospital
Kuopio , , Finland
Oulu University Hospital
Oulu , , Finland
Tampere University Hospital
Tampere , , Finland
Turku University Hospital
Turku , , Finland
Saint Louis Hospital
Paris , , France
Institut Gustave Roussy
Villejuif , , France
Queen Elizabeth Hospital
Birmingham , , United Kingdom
Velindre Cancer Centre
Cardiff , , United Kingdom
Christie Hospital
Manchester , , United Kingdom
Churchill Hospital
Oxford , , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

76

Study ID:

NCT01429064

Recruitment Status:

Completed

Sponsor:


Orion Corporation, Orion Pharma

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
Clinical Trials Can be Life-Saving for Some
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider